Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trial-Reference-Cited by-同舟云学术

Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trial

Published:2016-04 Issue:4 Volume:15 Page:373-381
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Cohen Jeffrey A,Arnold Douglas L,Comi Giancarlo,Bar-Or Amit,Gujrathi Sheila,Hartung Jeffrey P,Cravets Matt,Olson Allan,Frohna Paul A,Selmaj Krzysztof W

Publisher

Elsevier BV

Subject

Clinical Neurology

Reference27 articles.

1. Sphingosine 1-phosphate receptor signaling;Rosen;Annu Rev Biochem,2009

2. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists;Mandala;Science,2002

3. Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis;Cohen;Ann Neurol,2011

4. Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial;Calabresi;Lancet Neurol,2014

5. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis;Kappos;N Engl J Med,2010

Cited by 155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Sphingosine 1-Phosphate Receptor Modulators for Ulcerative Colitis;Journal of Clinical Gastroenterology;2024-08-08

2. Current understanding of cardiovascular autonomic dysfunction in multiple sclerosis;Heliyon;2024-08

3. Intracerebral haemorrhage in multiple sclerosis: assessing the impact of disease-modifying medications;European Journal of Medical Research;2024-06-25

4. Race and ethnicity in multiple sclerosis phase 3 clinical trials: A systematic review;Multiple Sclerosis Journal;2024-06-07

5. Updated Study Data for Ozanimod in Relapsing Multiple Sclerosis;American Medical Journal Neurology;2024-05-30